Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 1;6(7):ofz312.
doi: 10.1093/ofid/ofz312.

Positive Impact of a Point-of-Care Molecular Influenza Test in the Emergency Department During the 2017-2018 Seasonal Influenza Epidemic

Martin Martinot  1 , Valentin Greigert  1   2 , Simon Gravier  1 , Stephane Klein  1 , Magali Eyriey  3 , Anne Pachart  3 , Jean-Daniel Kaiser  4 , Mahsa Mohseni Zadeh  1 , Dominique De Briel  5 , Yannick Gottwalles  6 , Eric Thibaud  6
Affiliations

Positive Impact of a Point-of-Care Molecular Influenza Test in the Emergency Department During the 2017-2018 Seasonal Influenza Epidemic

Martin Martinot et al. Open Forum Infect Dis. .

Abstract

During the 2017-2018 flu epidemic, the point-of-care Alere-i (n = 72) and reverse transcription polymerase chain reaction (n = 106) tests were compared. Patients in the point-of-care group were administered oseltamivir significantly more rapidly (9 hours vs 23 hours), they spent less time in the emergency department, and they had lower rates of antibiotic administration and hospitalization.

Keywords: influenza; nucleic-acid amplification test; oseltamivir; point of care; seasonal flu.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Number of positive RT-PCRs and Alere NAATs performed and incidence of flu in Alsace during the 2017–2018 seasonal flu epidemic week (W) 50 (2017) to week 14 (2018). Abbreviations: NAAT, nucleic-acid amplification test; RT-PCR, reverse transcription polymerase chain reaction.
See this image and copyright information in PMC

References

    1. Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391:1285–1300. - PMC - PubMed
    1. Harper SA, Bradley JS, Englund JA, et al. Expert Panel of the Infectious Diseases Society of America Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003–32. - PMC - PubMed
    1. Hernu R, Chroboczek T, Madelaine T, et al. on behalf the “Flu in Lyon ICUs” Study Group Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis. Intensive Care Med 2018; 44:257–60. - PMC - PubMed
    1. Kumar A. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life. J Antimicrob Chemother 2011; 66:959–63. - PubMed
    1. Stewart RJ, Flannery B, Chung JR, et al. Influenza antiviral prescribing for outpatients with an acute respiratory illness and at high risk for influenza-associated complications during 5 influenza seasons-United States, 2011-2016. Clin Infect Dis 2018; 66:1035–41. - PMC - PubMed